Target intelligence / Profile preview

EMC1 antisense RNA 1 (EMC1-AS1)

Target
EMC1-AS1
Molecular classification
Long non-coding RNA (lncRNA)
01

Overview

EMC1 antisense RNA 1 (EMC1-AS1) is a **long non-coding RNA (lncRNA)** transcribed antisense to the EMC1 gene[3][7]. It is located on chromosome 1:19,210,330-19,240,709 (hg38)[5][7]. The current literature and curated gene databases identify EMC1-AS1 as being affiliated with the lncRNA genetic class but do not describe specific functional biological roles, molecular mechanisms, or involvement in signaling pathways[3][7]. Some database associations include a link with cerebellar atrophy, but there is no published evidence that it functions as a therapeutic target, biomarker, or has reported interactions with drugs or diagnostic/monitoring value in clinical practice[3][5][7]. No safety or therapeutic challenges are reported in major gene databases[3][7].\n\n**Additional Notes:**\n- This gene should not be confused with EMC1 (ER membrane protein complex subunit 1) or EMC3-AS1, which are distinct loci with different functions and clinical contexts[1][2][4].\n- Most scientific and clinical research focuses on its gene neighbor (EMC1), and there are currently no studies identifying EMC1-AS1 as a druggable therapeutic target, receptor, enzyme, transporter, or drug interaction partner.\n\n**Summary:**\nEMC1 antisense RNA 1 (EMC1-AS1) is a non-coding RNA locus with limited functional characterization, not considered a direct therapeutic target, and has no reported direct disease or drug interactions in current scientific literature and major genetic databases[3][7].

Other names
EMC1-AS1
02

Biological functions

Unknown
03

Disease associations

Cerebellar atrophy (association)

Beyond the preview

Go deeper on EMC1 antisense RNA 1 (EMC1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on EMC1 antisense RNA 1 (EMC1-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call